BridgeMD
New treatment option for Cardiovascular Diseases
Official title EValuation Of poLygenic Scores and CT imAging In Risk Factor Modification in Patients With diabEtes
ClinicalTrials.gov ID: NCT07091162
What this study is testing
- What it's testing
- This study is a three-arm, parallel-group, randomised controlled trial evaluating the effect of using cardiac CT imaging or polygenic risk score in cardiovascular risk factor modification in patients with diabetes.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Age 40 years or older
- Established diagnosis of T2DM
- Having acceptable imaging quality as deemed by the VHI-AICL
- Able to have a PRS calculated
You likely can't join if
- Unable to provide written informed consent.
- Unwilling to be followed for serial evaluation
- Clinically manifest CV disease
- Evidence of clinically significant coronary disease on CT that would preclude masking from participant's treating clinician for the duration of the...
- Unable to participate in the study or complete protocol required assessments in the opinion of the Investigator
The study team makes the final eligibility decision.
Where it's taking place
- Melbourne, Victoria, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Melbourne, Victoria, Australia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.